The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration’s ban on the practice and luring people away from Lilly’s […]
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro Read More »
Toronto , Canada – 20 June 2024; Andrew Feldman, co-founder and CEO of Cerebras Systems, speaks at the Collision conference in Toronto on June 20, 2024. Ramsey Cardy | Sportsfile | Collision | Getty Images Artificial intelligence chip developer Cerebras said Monday that it has obtained clearance from a U.S. committee to sell shares to
AI chipmaker Cerebras announces CFIUS clearance, a key step toward IPO Read More »
Michael Intrator, founder and CEO of CoreWeave Inc., Nvidia-backed cloud services provider, attends his company’s IPO at the Nasdaq Market in New York City on March 28, 2025. Brendan McDermid | Reuters Wall Street banks waited a long time for a billion dollar IPO from a U.S. tech company. They’re not making much money from
Wall Street banks got meager payout from CoreWeave IPO Read More »
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr. Read More »
People walk past an AMC theatre in Manhattan in New York City, U.S., February 25, 2025. Jeenah Moon | Reuters Hollywood’s blockbuster slate is heating up, and AMC Entertainment is increasing the number of its premium screens to meet demand. The world’s largest cinema chain is adding 40 Dolby Cinema theaters to its U.S.-based AMC
AMC bets on premium screens as Hollywood slate boasts big blockbuster titles Read More »
Value within the artificial intelligence industry is slowly shifting, from the companies developing models to the apps building on top of them. Early in the AI race, critics viewed apps like Perplexity, Replit, Sesame and Abridge as second-rate middlemen, slapping an interface on someone else’s technology. They were disparagingly known as AI wrappers: companies with
AI’s vibe-coding era: How the shift to apps changed the race Read More »
Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four
Canadians hold an “Elbows Up” protest against U.S. tariffs and other policies by U.S. President Donald Trump, at Nathan Phillips Square in Toronto, Ontario, Canada March 22, 2025. Carlos Osorio | Reuters Canadians are skipping trips to the U.S. and visitors from other countries could soon follow threatening to deepen the United States’ $50 billion
CoreWeave Inc. signage during the company’s initial public offering at the Nasdaq MarketSite in New York, US, on Friday, March 28, 2025. Michael Nagle | Bloomberg | Getty Images It wasn’t supposed to go down like this. The Trump presidency was set to usher in a rush of money to the markets, spurred by a
A sign is posted in front of Intel headquarters in Santa Clara, California, on Aug. 1, 2024. Justin Sullivan | Getty Images News | Getty Images Three members of Intel’s board of directors will not stand for reelection in May, the company said in a filing on Thursday. Omar Ishrak, former CEO of Medtronic; Risa Lavizzo-Mourey,
Intel announces three board members will retire following CEO shake-up Read More »
